GenMont Biotech

GenMont Biotech EBITDA per Share

The EBITDA per Share of GenMont Biotech (3164.TW) as of Nov 18, 2026 is 0.74 TWD. In the previous year, EBITDA per Share was 0.46 TWD — a change of 60.79% (higher).

EBITDA per Share

0.74TWD

YoY

60.79%

Last updated:

EBITDA per Share of GenMont Biotech is 2025 0.74 TWD. EBITDA per Share of GenMont Biotech was 2024 0.46 TWD. It decreases by 60.79% higher compared to the previous year.

The GenMont Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
1.38 TWD
Jan 1, 2019
0.87 TWD
Jan 1, 2020
0.89 TWD
Jan 1, 2021
1.65 TWD
Jan 1, 2022
0.69 TWD
Jan 1, 2023
0.08 TWD
Jan 1, 2024
0.46 TWD
Jan 1, 2025
0.74 TWD
The GenMont Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
0.74TWD+60.79%
0.46TWD+467.80%
0.08TWD-88.36%
0.69TWD-58.06%
1.65TWD+85.30%
0.89TWD+3.12%
0.87TWD-37.37%
1.38TWD+10.32%
1.25TWD+318.69%
0.30TWD-1,527.47%
-0.02TWD-98.80%
-1.75TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GenMont Biotech Stock analysis

What does GenMont Biotech do? GenMont Biotech Inc. is a biotechnology company based in Tainan, Taiwan, specializing in the research, development, manufacturing, and sale of probiotic supplements. Its products, including various strains of lactobacillus, target immune support against dust allergies and digestive health. The company operates domestically in Taiwan and internationally, having listed on the stock market in 2003. GenMont Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GenMont Biotech stock

EBITDA per Share of GenMont Biotech is 0.74 TWD in 2025.

EBITDA per Share of GenMont Biotech changed from 0.46 TWD to 0.74 TWD, representing a 60.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share GenMont Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — GenMont Biotech

All Key Metrics — GenMont Biotech